Rotator cuff tears are debilitating. What if you could take action to avoid them? Rabeeh Majidi, PhD founded OrthoKinetic Track to do just that through a wearable device and a predictive algorithm. Listen to our chat to learn more.
Highlights:
Sal Daher Introduces Rabeeh Majidi
What OrthoKinetic Track is Solving
"... What I would say is that orthopedic telemedicine lacks comprehensive physical exams..."
"... How is it that your system solves a problem that is of real interest to the providers?..."
"... it's not just about what you know, but also who you know..."
How Rabeeh Became an Entrepreneur
Parting Thoughts to the Audience
ANGEL INVEST BOSTON IS SPONSORED BY:
Transcript of “AI for Shoulder Injuries”
Guest: Rabeeh Majidi, PhD
Sal Daher: I'm really proud to say that the Angel Invest Boston Podcast is sponsored by Purdue University entrepreneurship and Peter Fasse, patent attorney at Fish and Richardson. Purdue is exceptional in its support of its faculty, faculty of its top five engineering school, in helping them get their technology from the lab out to the market, out to industry, out to the clinic. Peter Fasse is also a great support to entrepreneurs.
He is a patent attorney specializing in microfluidics and has been tremendously helpful to some of the startups in which I'm involved, including a startup, came out of Purdue, Savran Technologies. I'm proud to have these two sponsors for my podcast.
Sal Daher Introduces Rabeeh Majidi
Welcome to Angel Invest Boston, conversations with Boston's most interesting angels and founders. I'm Sal Daher, an angel investor who is delighted to figure out how to best build technology companies. Today, we are very lucky to have with us Rabeeh Majidi, PhD, founder of OrthoKinetic Track. Welcome, Rabeeh.
Rabeeh Majidi: Thank you for having me, Sal.
Sal Daher: Awesome. What problem is OrthoKinetic Track solving?
What OrthoKinetic Track is Solving
Rabeeh Majidi: Well, the pain point we are addressing with OrthoKinetic Track is the prevalence of rotator cuff tears, a leading cause of shoulder pain and disability, contributing to millions of physician visits and surgery in USA per year. While patient report and outcome measures have improved, assessing range of motion and strength through physical examination remains inconsistent and inaccurate. This can lead to delays in interventions, stiffness, and even something called adhesive capsulitis, a known problem after shoulder surgery.
Sal Daher: Tell me about capsulitis. I've got remains of a frozen shoulder. It's like my fourth frozen shoulder, and I'm doing my frozen shoulder exercises here. Just --
Rabeeh Majidi: Oh, are you willing to be my first customer then? [laughs]
Sal Daher: Yes, sure. Why not? The problem is that after surgery, for rotator cuff surgery, if you're not very careful, you're going to develop capsulitis, which is tightening of the capsule of cartilage around the joint, and it's an inflammation, and then you can't move. It's a cause of frozen shoulder and other maladies.
"... What I would say is that orthopedic telemedicine lacks comprehensive physical exams..."
Rabeeh Majidi: Exactly. It's a very known problem. To every 8 out of 10 people I was talking to to get their opinion about this idea, they were like, oh, we're are suffering from this, and I didn't know it was this common in people until I started this. My motivation actually came from this, this business is very personal to me. My mother, she lives overseas and after age of 40, this chronic shoulder pain become real problem for her, and that impacted her chronic quality of life. I saw the type of problem that people face when they have this frozen shoulder.
What I would say is that orthopedic telemedicine lacks comprehensive physical exams, and there is certainly a gap in orthopedic care. To fill this void OrthoKinetic Track offers personalized at-home solutions for rehabilitation and monitoring. There are a lot of camera-based systems and apps that they measure the range of motion of the people, but despite this camera-based system and mobile apps, our solution uniquely provides an in-depth muscle function and joint activity history after seeing both patient and clinician needs in the way that other solutions don't.
We're not just focusing on telling people what's your range of motion is, we're telling them in each range of motion, what is their muscle activity, which muscle is firing, which muscle is not, and then they can have a personalized treatment plan. Then because we're leveraging from AI, we can predict the level of stiffness in them, telling them, let's say, you're going to have this frozen shoulder in two months if you're not following this exercise regime, and then we can also prevent it from happening, so we are doing preventive and predictive algorithm to help the patients and doctors.
Sal Daher: Rabeeh, there's a reason at the back of my mind, there was something was telling me that this was a very interesting interview for me. [laughs] I think this is the ability to predict frozen shoulder because the frozen shoulder is something, it's a reality when you get past 40 and if you can do that, it's amazing, that's a really great thing. By the way, listeners, I was remiss when I introduced Rabeeh Majidi, PhD. I should have mentioned that prior to starting her company, she was a researcher in wearables and sensors, so she comes with this background, and now she's doing it with her company.
Your mom had a problem, a very severe problem with frozen shoulder, and now you've created this product to detect range of motion to do things that current state of the art does not do, which is right now they're using cameras to see how much people could move and everything else, but they're not actually knowing what muscle mass and what muscle is moving, how much strain there is. Can you go into a little bit the mechanism that you're using, the sensors that you're using, and what you're looking for? Unless it's like trade secret and you don't want to divulge it.
Rabeeh Majidi: Sure I would like to explain a little bit about the technology. What we are offering, it's a flexible brace that it has built-in sensors and gyroscope in it that it has specifically captures the data from the muscle activity and joint kinematics. Let's say our aim is to help with the telehealth. That if actually after the pandemic, this acceptance of remote healthcare rise up and then just we were like, orthopedic care doesn't have anything to help them with the telemedicine. The doctor calls you, they tell you that, what's your pain level today? What's your range of motion today? Tell me from 1 to 10 how much your pain is today, but there is no accurate way of measuring this over the telehealth center.
Sal Daher: There's no objective way of quantifying this.
Rabeeh Majidi: Exactly. What we are offering, it's a flexible brace that the person is going to wear that brace, and while the doctor asks the patient to do a specific movement like forward elevation, abduction, external rotation, all the exercises that they're asking in during the in-person visit, the person does that exercise and then that sensors is going to capture the range of motion and all the muscle activity, and provides a classified categorized information to the doctor and also to the patient. Patient only sees the range of motion, but doctor sees muscle activity in each range of motion.
You are doing the external rotation, what are the muscles that they are involved in this? If there is one muscle that's not firing, other muscles should overreact, and that's not good for the body. In this way, a person can get to know about their body. The way the system works, there is actually a mobile app that it's through the Bluetooth, it gets connected to that brace, the data is going to be captured through sensors, through the mobile app, comes to the cloud. On the cloud, there is AI algorithm that does all the stuff that it needs to do.
The machine keeps training itself. Then it provides feedback to the healthcare provider and to the patients. It continuously can monitor what patient does. They don't have to wear the brace all day long. They just wear it 5 to 10 minutes per day, do the rehabilitation, and then they can just see the trend of their progress. There are a lot of different ways of using it. During the telehealth, patient can wear the brace. During the physical therapy for at-home physical therapy, they can use it, so they don't need to go to the physical therapy centers with a caregiver or someone.
At the ease of sitting on their couch, they can do the physical therapy and somebody is watching them. Then there are actually a lot of sensors out there that physical therapist may use them in their clinic, but there is always a problem that what if the technician doesn't put the sensor in the right place on the right muscle? Because everything is built in in this device, nobody is worried about the human error. Then you're not worried that you're not seeing the same technician every time because even so that the technician is different person, still you have the same trend, same data that everybody can visit that.
Also, there is no gap between physical therapist and orthopedic surgeon. Now you go to the surgery, doctor doesn't know who's going to be your physical therapist, but since everything is going to be integrated into the EMR system, so doctor, physical therapist, and patient, they can all talk to each other, see the progress, see the trend. Someone is playing golf, so they want to know pre and post rehabilitation, what's their status. They use the device, they play the golf, and they can see their progress. It can help a lot of people, I would say.
Sal Daher: Now, what is exactly the industry pain point that you're solving with this? Because I can see it from the point of view of the user, how it's really valuable, but the people who are going to pay you for your product, it's not going to be the individual, it's going to be the providers.
Rabeeh Majidi: Hospitals.
Sal Daher: The hospitals. Exactly. What problem are you solving for them?
Rabeeh Majidi: The problem is we don't have accurate way of measurement during the physical exam, and we don't have any personalized treatment plan. If you have rotator cuff problem, you go to the physical therapist, they gave you a bunch of exercises that's good for shoulder. They don't know what's really happening in your body, which muscle is not firing, what's the real problem. Either you have another tear after the surgery or not. I would say we're providing the personalized treatment plan, and we're solving the lack of having accurate data.
"... How is it that your system solves a problem that is of real interest to the providers?..."
Sal Daher: That answers the question with regards to the patient. I have no doubt that this is a great benefit to the patient, but providers are not necessarily interested in things that benefit the patient. They're interested in things that pay for them. How is it that your system solves a problem that is of real interest to the providers?
Rabeeh Majidi: We are saving clinician time so they can admit more patients. We are solving the problem for doctors that-- and they have to ask patient, go through a lot of imaging and then a lot of multiple visits. We help them with the diagnostic. We can help with the preop, so making better decisions, making the personalized treatment plan for their patients. We are increasing the patient satisfactions. They're going to say, this back brace did this, they found the problem immediately. Then in terms of the providers and insurance, we are providing internal health, so we are significantly lowering the cost.
Sal Daher: You're lowering the cost?
Rabeeh Majidi: Saving clinician time, reducing the rehabilitation period for the patient. It's a win-win for everyone.
Sal Daher: Have you had conversations with the payers, the insurers, with regards to this?
Rabeeh Majidi: Yes. It's a little bit soon for the payers to adopt to this process. Telehealth is something new. We don't have a real customer at the moment, but we had a conversation with the payers and insurers that they would like to consider it because they liked the idea. We also had conversations with the wellness centers. They were like, we have a lot of members that they would love to know about this so they have some private insurers to pay for them, so they would love to become partner with us.
Sal Daher: I wonder if, just idle speculation here, if there isn't room for this as a device that's direct to consumers, because depending on the cost of this, heck, if it can predict frozen shoulders, I'd buy it in a minute. If you've had one frozen shoulder, you're going to be easy bait for this product. I pay $500 for this. I put it on once a week. It measures my range of motion, it measures the muscles and so forth. You've got a little algorithm that says " Sal, you'd better start doing this or that because your capsule's getting tighter, you're going to have a frozen shoulder coming up soon". I'd pay for this. Of course, I don't know how you would separate yourself. You can't make a claim if it's not a device that's cleared by the FDA.
Rabeeh Majidi: It's a class two device in worst case scenario. If we are working with wellness centers, it would be very low risk or it would be in the class one category, but if we're working with hospitals, because it provides feedback for the patients and it's a software for the service, it would be the class two device based on my feedback I got from the regulatory people.
Sal Daher: What kind of challenges have you faced seeking funding for this project?
Rabeeh Majidi: The big problem I was facing was as a woman and as an immigrant in this such of world, it has its own unique challenges.
Sal Daher: Sure.
Rabeeh Majidi: One major hurdle is breaking down the pre-convinced notions and biases that, oh, are you the person who going to make this happen, and sometimes, there is a need to work harder to prove yourself and your idea. It happened to me that I initiated partnership with one of the wellness centers, and then at first the person was like, oh, I don't think we're going to need this. Then I have to push it until I get the first meeting. Then when I talked to them, the guy was like, oh, I'm 100% in, I would love to have such things, but I totally misunderstood what your goal is. It's very tough market at the moment, so you really have to prove yourself.
Sal Daher: It is difficult, yes.
Rabeeh Majidi: You really have to have a prototype that it's at least very close to the final product when you're reaching to the investors. They want to see and not just visualize how it's going to do this. I've been focusing on a lot of marketing aspect of this, providing educational videos and a lot of things to make sure that people are on the same page with me. It's way much harder than few years ago for at least such a startup like us. Also, the device by itself, it's not very risky. The strong team that we have, everybody's like, we are sure that you can make it happen.
The problem is everybody was like, who's going to pay, who's ready for digital health? They want to see the actual customers who's paying for this. It's a little bit getting harder because the medical device, they are still using the traditional way of dealing with the patients. Then it's very hard for them to let this happen that much quick. I see a lot of the startups like me, they're facing the same challenges for the digital health because the adoption process is very slow, and fundraising is affected by that.
Sal Daher: Have you joined any accelerator? Have you avail yourself of any of the resources around here to help you hone your message, such as M2D2?
Rabeeh Majidi: Yes, we've been part of M2, UMass Lowell, M2D2, cycle 5, which was all orthopedic.
Sal Daher: Excellent.
Rabeeh Majidi: The first incubator I joined was MIT Enterprise Forum of Cambridge. Now they call it E Forum. It was a very great incubator that taught a lot of basics of the startup, no matter that I'm in medical device or whatever, but then M2D2 was very focused on the orthopedic, and then I joined Eddies, the Mass Innovation Network. We are now part of that, and actually tonight we have a pitch event that I'm presenting there.
Sal Daher: Best of luck.
Rabeeh Majidi: Thank you.
Sal Daher: You're covering the basis with regards to that. How did you leverage your connections to get your startup off the ground? Was there a particular trick that you employ to get people to focus on what you're doing? Because focus is everything. It's like getting sufficient focus on your project, will move it forward. The problem is there are a lot of distractions. How did you do that?
Rabeeh Majidi: Leveraging the connection, I would say, has been a pivotal strategy in building OrthoKinetic Track. My background in electrical engineering, coupled with my certificate from Harvard Business School, so it actually allowed me to tap into diverse network of professionals.
Sal Daher: You had a network that spanned electrical engineers and people in the business school, and so forth. That helped you, instead of just coming from a background of specifically just a scientific background or engineering background.
Rabeeh Majidi: Yes, I had both academia and industry background, so I leveraged from both. I would say I use the time swinging method. I asked people around me who know me, who trust me to do the work that I wanted to do, and then they were willing to do that for me. At the end of the day, it would be a win-win. I would say without their help, I couldn't be where I am now, we did high-level pilot study.
We presented at scientific conferences. One of the famous conferences in orthopedic, which is ORS, Orthopedic Research Society. Then there are hundreds of orthopedic surgeons are there. Then without being biased about me, my personality, they had the feedback about this idea, and that was great. This was not happening without the help of people in my network who supported me to do this pilot study in the cheapest, quickest way that I could do. I'm very grateful to have them around me.
Sal Daher: It's fair to say that you read that very important business founders text. Stone Soup.
Rabeeh Majidi: Yes.
[laughter]
Sal Daher: Listeners who aren't familiar with Stone Soup. Look up. It's a kid's book called Stone Soup.
"... it's not just about what you know, but also who you know..."
Rabeeh Majidi: I would say it's a reminder that sexes in the startup, it's not just about what you know, but also who you know.
Sal Daher: How you motivate them to bring out the cabbage for the soup or the bread, or the onions, or the beans, and so forth to add to your soup.
Rabeeh Majidi: Exactly.
Sal Daher: Very good. Rabeeh Majidi, where are you now in terms of your startup? Do you have a finalized prototype? Are you actually measuring people's muscle range of motion, and so forth?
Rabeeh Majidi: I would say we don't have a final prototype, but we had a minimum viable product that we could start at least looking into the muscle data, and we did that. We had some people who referred to us from, UMass, so their hospital. They volunteered to be part of this study. Then, as I mentioned, we did high-level pilot study. Basically they passed the proof of concept. We know that it's going to work. We derisked the product development. Moving forward for the FDA, we need to do more clinical studies.
We are looking for partnership with other hospitals, recruiting more patients and further focusing on development of this device. Still, we are halfway through this. Then in terms of a software, we know what we need, but in terms of the hardware, we need to make a final prototype, final brace. We actually found a manufacturing partner through FORGE Impact and we're working on that to making more prototype and expanding our clinical study.
Sal Daher: Awesome. That is very, very promising. Recently, I interviewed a founder who went through M2D2 as well, Ben Holmes. I don't know if you've met Ben.
Rabeeh Majidi: Oh, yes, I've met him.
Sal Daher: He has something that you can insert into a knee to replace cartilage. I look at these things, I say, my gosh, maybe 2027, somebody can have arthroscopic surgery and have cartilage replacement. Perhaps sooner. OrthoKinetic Track can be predicting frozen shoulders and preventing them.
Rabeeh Majidi: We're not just focusing on the shoulder.
Sal Daher: Capsulitis, period. What can be done when you detect that someone is tending towards capsulitis to prevent it from becoming critical?
Rabeeh Majidi: For preventive methods, basically, the system monitors the person. If they see there is a chance, so they see it like send a red flag to the provider and they say, this person is in this situation, don't leave them alone, schedule an in-person or virtual visit that they can closely monitor what's happening. Then maybe they need to adjust the treatment plan. Basically, the machine keep trains itself based on the history of the patient and the current situation. The patient has a medical history, and then they have a rehabilitation period. The machine keep training itself and then that's how it tries to prevent this from happening.
Sal Daher: The machine is training itself on inputs from the sensor from this harness that the patient is wearing?
Rabeeh Majidi: Also the history of the patient who had similar problem from before. It can be from another-- It does it from different ways. Usually the person doesn't have both shoulders affected, so it actually compares one affected shoulder with the one that actually doesn't have a problem. It also looking to the history of other people who were in the same age, same hand dominance, same sex. Whether female and male, they have different range of motion. Based on that, machine keep trains itself and also for these patients, and then try to bring the best for the patient.
Sal Daher: I wonder if it looks at additional variables in the EMR. Are you scanning the EMR for this data? Presumably the electronic medical records, electronic health records?
Rabeeh Majidi: Yes.
Sal Daher: I'm just wondering if machine learning can pick up other things that could be affecting someone. It might be an infection or something like that. Or the variables that you're looking at are just the input from your harness and looking for other frozen shoulders and so forth.
Rabeeh Majidi: We look into other biometrics data, as much as is related to the joint kinematics and muscle activity. I would say, for example, the oxygen level of the person. Because it's very important for the muscle when it does exercise, plus the oxygen level. We measure other biometrics data as well. It may or may not be useful for other diagnostic and other treatment purposes.
We are providing that data and we leverage if there's already a trend or something in the system that we know that this person had this history. For example, the person's range of motion for people who have diabetes is different than people who don't have diabetes. There's a lot of stuff that take into account. I would say those EMR data would matter. It's in form of help me help you. We provide data for others and also leverage getting data from others.
Sal Daher: You're exchanging data. It gets me thinking, because I wear a Fitbit and I also wear a WHOOP band. WHOOP is very good at picking up things like coffee consumption and how it affects your sleep, alcohol consumption, how it affects your sleep, things like that. When you have this going, you're going to have-- when you have a lot of patients, you're going to learn a lot.
You're going to discover some weird connection, I don't know, eating potato chips. I don't know how you get that into your EHR, but maybe blood pressure or something else is a marker. You're going to discover a lot. I wonder if the sports medicine direction isn't more, because I know that in the case of WHOOP, initially, they ended up going in the direction of sports. I have a vague memory of an interview with Will Ahmed.
Rabeeh Majidi: I just heard recently they had the lineup close, they're trying to measure some parameters related to sport medicine. I'm actually following them.
Sal Daher: Stalking them, good. Do stalk them.
[laughter]
Very good. Because they've done some very clever things. Excellent. Rabeeh Majidi, at this point what I'd like to do is a very quick promo for the podcast. I would like to invite listeners who are fascinated by the possibilities of what OrthoKinetic Track might do for them in the future, or are fascinated by the possibilities of repairing their knees with Ben Holmes' product, or other things. Richard Lesinski who was on, who has an algorithm for detecting nodules in X-rays, that picks up 83% when radiologists only pick up 49%. This is all exciting stuff. If you find this exciting, why don't you follow us on the app that you use to listen to podcasts?
Leave a rating and leave a review. Five stars. My mom asked me to ask for five stars. Also, leave a review. Rabeeh, you can do this when your podcast launches. The day it launches, if you use an Apple phone, for example, you can go to the Apple Podcast and leave a written review and a rating, and it'll get your podcast prioritized. It'll be seen by more people. Anyway, let's get back to how you decided to become an entrepreneur.
I know that your mom's suffering with her frozen shoulder and so forth was a motivation, but the response could have been search out a doctor to treat your mom. Why was the response, go out and create my own solution? Do you have an example of entrepreneurship in your family before? What is it that made you go in this very difficult path of starting a company instead of just taking a corporate job? Earning well and having a relatively calm life?
How Rabeeh Became an Entrepreneur
Rabeeh Majidi: It was a very interesting journey for me. My co-founder, he was in medical devices for 15-plus years. We've done a couple of research together on wearables.
Sal Daher: What is the name of your co-founder? Unless it's a trade secret.
Rabeeh Majidi: No, it's not Dr. Ali Kiapour. A-L-I K-I-A-P-O-U-R.
Sal Daher: Ali Kiapour. Excellent. Tell me about Dr. Kiapour.
Rabeeh Majidi: Dr. Kiapour has been in sports medicine and designing implants for the body for so many years. He knew about my expertise in sensor design. We worked on a couple of projects on variables together before for the ankle boots, smart adaptive ankle boots, and we realized that we could work very well together. I was working for a corporation that started having a startup inside the corporate, funded by the corporate. I joined that startup as a lead engineer. That's when I learned much about whatever I know now about the startups.
That was a benefit of being in the surroundings, in the startup environment. Then we didn't have a funding problem for that startup because it was directly coming from corporate. I attended a lot of training sessions and leadership, and a lot of stuff related to the startup culture that it actually makes me feel that, this is the next thing I want to do. Then COVID happened and then they asked some of us, we may want to go back to our previous department or-- It was a little bit different situation. That was the time that I left that startup, and I applied for a couple of jobs. Actually, I got two offers. Then I had this conversation with my co-founder that, this is the right time.
You had this experience working for a startup for a while, why didn't you start your own business? It happened that my mom was complaining about her shoulders. It was just coincidence. Something pushed me through this. Then I realized that, maybe it's the time. I would never leave my full-time job to start a company before experiencing the environment of the startup, but that was the right timing for me. I leveraged from that experience. I always appreciate, I still have connection to my previous, where there's that corporate and then startup company, there's still a mentor for me. I actually invited one of them to the Startup Boston Week that I'm volunteering for. He's going to be a mentor there.
Sal Daher: Far out.
Rabeeh Majidi: I still try to keep those nice people around me that I learned a lot from them.
Sal Daher: These industries, there are ecosystems, there's room for giraffes, there's room for elephants, there's room for armadillos. Different animals have a different part of the ecosystem. Some of them have expertise in doing things in scale. Others are more nimble and have expertise at discovering things that the larger animals may not be so good at discovering. They all have to be able to graze in the same environment somewhat peacefully and coexist. That is wonderful. Very good. Rabeeh Majidi, PhD, founder of OrthoKinetic Track, are there any other thoughts that you want to leave our audience of Angel investors, founders, people who are thinking of founding companies? Any thoughts that you want to convey?
Parting Thoughts to the Audience
Rabeeh Majidi: I would say all the founders like me, especially the first-time founders, they may not just pursuing the money. They may have a big dream and big passion about what we're doing. Specifically in my case, I would be cautious about the money that investors are giving to me to be honest, direct, and try to be beneficial for them. At the same time, one of the important things for a lot of founders is their product is like their baby. They want to raise it, and they want to make it something meaningful to make this world a better place for people to live. I would leave this comments with the very quick example I had. Recently I was hospitalized with the pneumonia, and then there was this lady next to me that she was around seven-year-old, and then she was crying in the hospital that I don't want to go to a nursery home. Apparently she had COVID and then because of COVID she lost her muscle functions. Then someone from Medicare was there and then trying to convince her that you can go to this five-star nursery home, this is the best for you. She's like, I don't know anyone there in my age.
I don't have any family friends there. I know this is five star, I want to be surrounded by my family. Why I can't have this rehab while I'm at home? They're like, this is not possible at this stage for you. I realize a device like this can be a life changer for a lot of people. Change the way that people are living and then caring about the people around them. Not all the founders they're just looking for having a million-dollar, billion-dollar company. They really mean it when they start doing this. They want to make a big change in life of people.
Sal Daher: As an investor, one of the things that we look for is a founder who has a mission to build a company that is other than a financial interest, because frankly, starting startups is a bad business. [laughs] You have a much better chance of just being financially rewarded by staying in your job. These are very intelligent, very well-accomplished people, they could just continue earning a salary. If they are motivated enough to do this irrational thing, you say, oh, this is someone who could make water go uphill, so that, you take notice.
That's the difference, because if someone thinks they're doing it because they're going to make money, you say, oh, this person likely is not going to stick it out. Because they're going to discover sooner or later that there are easier ways to make money instead of building a startup, which is a dashed hard thing. You have to really be motivated. It can be extremely rewarding if you do it successfully, but there's going to come a time when you're just going to say, ah, heck throw in the towel. Find something easier to do.
Rabeeh Majidi: I'm glad to hear that from you. I happened to present to an investor that his first question was does your 1 plus 1 equals 33? I was like, you even don't know what problem I'm solving. That question got me a little bit that if this is the right thing I'm doing now, do I want to pursue this conversation? It didn't work out at the end, I would say. It seems like we didn't have the same interest. I'm glad that you brought this up that it's the mission truly matters.
Sal Daher: Eventually, you will make money. If you are really, really dedicated, you have a good chance of making money, but that can't be the goal. Because then you're just going to say, ah, give up, just easier way to make money elsewhere. Excellent. Rabeeh Majidi, PhD, founder of OrthoKinetic Track. I'm very grateful to you for making time to be in the Angel Invest Boston Podcast.
Rabeeh Majidi: Thank you, Sal. It's a pleasure.
Sal Daher: I want to thank my listeners for tuning in and listening, and also going and following us, leaving a review, leaving a rating. This is Angel Invest Boston. I'm Sal Daher.
[music]
I'm glad you were able to join us. Our engineer is Raul Rosa. Our theme was composed by John McKusick. Our graphic design is by Katharine Woodman-Maynard. Our host is coached by Grace Daher.